BVXV BiondVax Pharmaceuticals Ltd. ADRs

BiondVax Pharmaceuticals Ltd is a clinical stage biopharmaceutical company. The Company is engaged in developing, manufacturing and commercializing immunomodulation therapies for infectious diseases. This is an ADR of a company that does not have its stock publicly traded anywhere else in the world.

$2.34  +0.13 (5.88%)
As of 10/18/2021 14:35:39 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Israel
Country of incorporation:  Israel
IPO date:  05/12/2015
Outstanding shares:  11,353,634
Average volume:  72,010
Market cap:   $24,864,458
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    09073Q105
ISIN:        US09073Q1058
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   3.62
PS ratio:   0.00
Return on equity:   184.78%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy